|
Average length of attack (days)
|
2.66±1.5
|
3.03±1.2
|
0.073
|
|
Abdominal attacks
|
50 (87.7%)
|
48 (85.7%)
|
0.788
|
|
Arthritis attacks
|
52 (91.3%)
|
28 (50%)
|
<0.0001
|
|
Pleuritis attacks
|
36 (46.2%)
|
18 (38.2%)
|
0.0013
|
|
Exertional leg-pain
|
47 (82.5%)
|
36 (64.3%)
|
0.034
|
|
ELE attacks
|
10 (17.5%)
|
3 (5.4%)
|
0.073
|
|
Attacks of fever alone
|
20 (35.1%)
|
12 (21.4%)
|
0.143
|
|
Average colchicine dose (mg/day)
|
1.9±0.48
|
1.48±0.54
|
0.0001
|
|
IV colchicine treatment
|
5 (8.8%)
|
0 (0%)
|
0.057
|
|
Proteinuria or amyloidosis
|
6 (10.5%)
|
1 (1.8%)
|
0.113
|
|
Anemia of chronic disease
|
14/53 (26.4%)
|
7/52 (13.5%)
|
0.142
|
|
Elevated acute phase reactants
|
10/18 (55.6%)
|
4/16 (25%)
|
0.092
|
|
Chronic renal failure
|
6 (10.5%)
|
0 (0%)
|
0.027
|
|
Chronic arthritis
|
11 (19.3%)
|
2 (3.6%)
|
0.015
|
|
Work days lost each month
|
4.4±7.2
|
2.6±4.6
|
0.718
|
|
Harm to quality of life
|
(1-10) 5.6±3.3
|
4.1±3
|
0.013
|
|
Number of attacks per year w colchicine
|
7.2±7.8
|
3.5±5.5
|
0.0007
|
|
Number of attacks per year w/o colchicine
|
23.6±9.3
|
15.6±11.7
|
0.0001
|
|
Crohn's disease
|
4 (7%)
|
2 (3.6%)
|
0.679
|
|
Ankylosing Spondylitis
|
3 (5.3%)
|
1 (1.8%)
|
0.619
|
|
Behcet's Disease
|
7 (12.3%)
|
1 (1.8%)
|
0.061
|
|
Henoch Schonlein Purpura
|
1 (1.8%)
|
0
|
1
|
|
All FMF associated diseases
|
17 (29.8%)
|
7 (12.5%)
|
0.0373
|
